Aytu Biopharma AYTU Cash Flow Statement (2010-2026)

NASDAQ AYTU
$2.00 +0.04 (+2.04%)
As of: Oct 20, 2026 · 1:27 PM EDT
Reported Financials

Aytu Biopharma Quarterly Cash Flow Statement

Periods 62 quarters
Latest Jun 2026

Aytu Biopharma reported cash from operations of $4.41M and free cash flow of $4.39M for the quarter ended Jun 2026, up 57.2% year over year. This cash flow statement covers 62 quarters of results from Nov 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Feb2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-27.85M-11.55M-53.29M-16.09M-0.70M-6.69M-7.20M-2.46M-8.12M-0.22M-2.89M-4.62M1.47M0.79M3.99M-19.82M1.97M-10.58M-5.62M-0.02M
Depreciation and DepletionDep. & Depletion
0.40M0.40M0.50M0.30M0.30M0.40M0.30M0.30M0.30M0.30M0.20M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
-0.16M-0.17M0.10M0.14M0.15M0.17M0.10M0.15M0.15M0.15M0.16M0.13M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF)Dep. & Amort.
2.68M2.68M2.57M2.22M2.30M2.21M2.19M2.12M2.23M1.40M1.53M1.56M1.33M1.29M1.29M1.46M0.80M0.89M1.12M1.12M
Share-based CompensationStock Comp.
1.52M1.23M1.27M1.23M1.18M3.07M0.90M0.90M0.93M0.82M0.81M0.35M0.17M0.15M0.14M0.11M0.11M0.28M0.15M0.15M
Deferred Taxes
Cash from Discontinued OperationsCash from Discont. Ops
0.65M0.84M0.60M1.24M-0.38M-0.12M-0.05M-0.06M
Gains from Sales and DivestituresGains Divest
0.10M-0.01M0.04M
Gains from Investment SecuritiesGains Investment
-0.01M1.61M2.19M1.40M2.57M-1.37M-5.91M-0.58M1.02M1.46M2.88M3.02M2.26M-9.86M3.78M-8.24M-1.26M0.98M
Asset Writedowns and ImpairmentWritedown
19.45M0.10M45.20M10.81M0.10M2.60M0.10M3.11M0.10M0.10M0.10M1.08M0.10M0.10M0.10M8.06M0.30M0.80M0.70M0.40M
Cash from Restructuring
Other non-cash itemsOther Non-Cash
0.22M0.28M-1.47M0.69M0.08M-0.23M-0.96M0.92M-0.38M-0.01M0.03M1.11M0.04M
Change in Working Capital
Change in ReceivablesChange Receivables
-6.53M1.34M4.54M-5.89M6.21M-2.38M8.50M-5.18M0.95M0.62M-1.04M-5.73M-0.48M2.27M10.51M-4.67M2.07M-2.30M-6.43M-1.71M
Change in InventoryChange Inventory
0.18M0.39M-0.66M-1.21M2.10M0.08M0.80M0.62M1.02M0.78M1.01M2.01M-0.33M-0.63M0.06M0.52M-1.06M-0.61M-0.54M-0.18M
Change in Account PayablesChange Payables
-9.89M6.58M-4.79M0.42M3.59M-4.43M4.56M-1.34M0.91M-3.98M0.85M0.13M3.14M-1.81M0.40M-1.44M1.74M-1.08M-1.05M-1.93M
Change in Accured ExpensesChange Accured Exp.
3.33M-3.94M1.87M-14.54M-3.48M2.47M8.04M-3.43M-5.17M1.61M0.16M-5.77M-4.97M7.31M1.61M-3.06M-1.64M3.46M-5.89M0.94M
Change in Other Operating AssetsOther Assets Change
-0.28M2.18M-3.30M-0.82M1.80M2.81M-1.00M-4.45M-1.13M1.96M-0.64M-0.52M-0.12M0.80M1.65M-1.88M-0.48M1.48M2.03M-2.85M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
0.15M-0.10M0.00M0.00M-0.07M0.00M-0.01M-1.79M3.74M0.06M0.04M-0.05M0.10M0.21M0.05M0.17M0.40M0.18M0.17M-0.05M
Other Operating ActivitiesOther Ops.
-0.06M-0.03M-0.07M0.09M-0.03M0.04M0.00M-0.01M-0.01M
Cash from OperationsCash from Ops.
-3.80M-8.81M-9.12M-7.10M-9.15M-2.45M-2.90M9.37M-0.21M-0.14M-0.25M-0.79M-1.19M2.91M-6.46M2.80M-0.62M3.68M-4.18M4.41M
Investing Activities
Capital ExpendituresCapex
0.33M0.14M0.01M0.07M0.02M0.02M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.52M0.15M
Change in Property, Plant and EquipmentChange in PP&E
-0.33M0.38M0.15M-0.07M-0.02M-0.02M-0.01M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Other Investing ActivitiesOther investing
-0.09M-3.05M-0.07M-0.04M0.04M-0.01M0.00M-0.16M-0.08M-0.17M-0.05M-0.03M
Cash from Investing ActivitiesCash from Investing
-0.09M-3.05M-0.07M-0.04M0.04M-0.01M0.00M-0.16M-0.08M-0.17M-0.05M-0.03M0.38M0.15M-0.07M-3.02M-0.02M-0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
42.21M46.65M-73.86M
Long-Term Debt RepaymentsLT Debt Repayment
0.03M89.61M-73.56M0.03M0.03M-0.03M0.07M0.02M0.02M0.02M0.03M15.65M0.46M0.47M0.46M0.46M0.46M0.47M0.46M0.46M
Non-Current Debt
42.19M-42.96M-0.30M-0.03M-0.03M0.03M-0.07M-0.02M-0.02M-0.02M-0.03M-15.65M-0.46M-0.47M-0.46M-0.46M-0.46M-0.47M-0.46M-0.46M
Short-Term Debt issuancesST Debt Issuance
42.21M39.77M34.79M
Short-Term Debt repaymentsST Debt Repayment
45.63M39.35M30.52M
Current Debt
-3.41M-3.77M0.43M4.27M-0.66M2.97M-8.84M-0.35M-0.19M0.56M0.81M1.88M-0.26M6.02M-0.97M5.81M-5.80M1.34M-4.34M
Net Debt Issuances and RepaymentsNet Debt Issuance
38.77M-42.96M-4.07M0.40M4.25M-0.63M2.90M-8.86M-0.37M-0.21M0.53M-14.84M1.41M-0.72M5.55M-1.43M5.35M-6.26M0.87M-4.80M
Change in Capital Stock
Common Stock IssuedStock Issued
0.31M4.52M7.88M-1.01M10.42M1.16M1.44M2.56M3.38M14.84M
Net Shares Issued and RepurchasedNet Shares Issued
0.31M4.52M7.88M-1.01M10.42M1.16M1.44M2.56M3.38M14.84M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.31M4.52M7.88M-1.01M10.42M1.16M1.44M2.56M3.38M14.84M
Other financing activitiesOther financing
-0.01M-0.17M0.00M0.61M-0.81M-0.26M-0.07M1.05M-0.16M-0.11M-0.05M
Cash from Financing ActivitiesCash from Financing
-5.46M6.59M1.52M-1.12M13.56M-1.87M2.58M-5.40M-2.73M-0.13M0.53M1.07M0.91M-2.76M4.30M12.99M2.30M-6.26M0.87M-4.80M
Additional items
Change in Cash
-9.34M-5.28M-7.66M-8.25M4.45M-4.31M-0.32M3.81M-3.02M-0.44M0.23M0.25M0.10M0.29M-2.23M12.78M1.68M-2.61M-3.31M-0.41M
Ending Cash Balance
35.28M27.61M19.36M23.81M22.99M19.18M22.99M19.96M19.53M19.76M20.01M20.11M20.40M18.17M30.95M32.63M30.03M26.72M26.31M
Free Cash FlowFCF
-3.80M-8.81M-9.12M-7.10M-9.15M-2.45M-2.90M9.37M-0.21M-0.14M-0.25M-1.12M-1.33M2.90M-6.52M2.79M-0.62M3.66M-4.18M4.39M
Net Cash FlowNCF
-9.35M-5.27M-7.66M-8.25M4.45M-4.32M-0.32M3.81M-3.02M-0.44M0.23M0.25M0.10M0.29M-2.23M12.78M1.68M-2.61M-3.31M-0.41M
Interest Paid
1.69M0.67M0.72M0.07M0.57M1.46M0.84M0.95M1.36M0.81M0.99M0.88M0.37M0.39M1.17M0.90M0.47M0.50M0.83M
Income Taxes PaidTaxes Paid
0.13M1.05M0.45M0.97M0.14M0.06M0.01M

Aytu Biopharma Cash Flow Statement API

Pull Aytu Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AYTU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY